Outlook Therapeutics Inc.
OTLK | NASDAQ
$0.70
+$0.01 (+2.00%)
Sep 22, 2026, 1:32 PM ET · Market open
Fiscal Quarter Period Ending | Q3 2026 Jun 29, 2026 | Q2 2026 Mar 30, 2026 | Q1 2026 Dec 30, 2025 | Q4 2025 Sep 29, 2025 | Q3 2025 Jun 29, 2025 | Q2 2025 Mar 30, 2025 | Q1 2025 Dec 30, 2024 | Q4 2024 Sep 29, 2024 | Q3 2024 Jun 29, 2024 | Q2 2024 Mar 30, 2024 | Q1 2024 Dec 30, 2023 | Q4 2023 Sep 29, 2023 | Q3 2023 Jun 29, 2023 | Q2 2023 Mar 30, 2023 | Q1 2023 Dec 30, 2022 | Q4 2022 Sep 29, 2022 | Q3 2022 Jun 29, 2022 | Q2 2022 Mar 30, 2022 | Q1 2022 Dec 30, 2021 | Q4 2021 Sep 29, 2021 | Q3 2021 Jun 29, 2021 | Q2 2021 Mar 30, 2021 | Q1 2021 Dec 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 9K | 127.44K | -1.21M | -91.79K | 1.51M | n/a | n/a | 170.12K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 17K | 149.33K | 29.63K | 916.52K | 439.82K | n/a | 28.8K | 85.06K | 28.67K | 28.2K | 28.2K | 11.22K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -8K | -21.89K | -1.24M | -1.01M | 1.07M | n/a | -28.8K | 85.06K | -28.67K | -28.2K | -28.2K | -11.22K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -10.81M | -14.03M | -13.48M | -17.31M | -15.75M | -12.39M | -21.61M | -22.88M | -19.56M | -18.94M | -10.32M | -12.46M | -18.14M | -6.84M | -15.69M | -13.99M | -17.02M | -18.91M | -13.15M | -13.44M | -11.48M | -12.63M | -14.19M |
Interest Income | n/a | 3 | n/a | n/a | n/a | n/a | 48.88K | 239.95K | 404.59K | n/a | 188.68K | 305.82K | 395.54K | 187.79K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -20.28M | -4.45M | -23.06M | -14.85M | -20.15M | -46.35M | 17.38M | 5.69M | 44.41M | -114.29M | -11.18M | -12.99M | -20.68M | -6.65M | -18.66M | -14.34M | -17.54M | -19.7M | -14.46M | -13.4M | -12.2M | -13.11M | -14.46M |
Net Income | -20.32M | -4.45M | -23.06M | -13.29M | -20.15M | -46.36M | 17.38M | 5.69M | 44.41M | -114.29M | -11.18M | -12.99M | -20.68M | -6.65M | -18.66M | -14.35M | -17.54M | -19.71M | -14.46M | -13.4M | -12.2M | -13.11M | -14.46M |
Selling & General & Admin | 7.55M | 9.5M | 8.61M | 10.33M | 9.68M | 7.98M | 11.95M | 10.35M | 8.36M | 5.43M | 5.79M | 7.52M | 7.04M | 6.29M | 5.83M | 5M | 5.78M | 6.69M | 3.28M | 3.5M | 2.93M | 4.1M | 2.24M |
Research & Development | 3.25M | 4.5M | 3.63M | 5.98M | 7.13M | 4.41M | 9.66M | 12.52M | 11.2M | 13.51M | 4.53M | 4.94M | 11.1M | 544.95K | 9.86M | 8.99M | 11.25M | 12.22M | 9.87M | 9.94M | 8.55M | 8.53M | 11.95M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -29K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 10.8M | 14.01M | 12.25M | 16.31M | 16.81M | 12.39M | 21.58M | 22.88M | 19.56M | 18.94M | 10.32M | 12.46M | 18.14M | 6.84M | 15.69M | 13.99M | 17.02M | 18.91M | 13.15M | 13.44M | 11.48M | 12.63M | 14.19M |
Interest Expense | n/a | n/a | n/a | 264.16K | 49.35K | 18.5K | n/a | n/a | n/a | 3.08M | n/a | n/a | 303 | n/a | 2.45M | 360.65K | 356.95K | 418.33K | 351.53K | 269.18K | 256.87K | 250.41K | 159.66K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 298 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 10.82M | 14.15M | 12.28M | 17.22M | 17.25M | 12.39M | 21.61M | 22.88M | 19.56M | 18.94M | 10.32M | 12.46M | 18.14M | 6.84M | 15.69M | 13.99M | 17.02M | 18.91M | 13.15M | 13.44M | 11.48M | 12.63M | 14.19M |
Income Tax Expense | 41K | n/a | n/a | -1.55M | n/a | 2.8K | n/a | n/a | n/a | 2.8K | n/a | n/a | n/a | 2.8K | n/a | 800 | n/a | 2K | n/a | n/a | n/a | 2K | n/a |
Shares Outstanding (Basic) | 136.74M | 81.84M | 60.21M | 34.8M | 36.96M | 30.87M | 24.23M | 18.55M | 23.28M | 14.27M | 13.01M | 13.01M | 12.84M | 12.83M | 11.37M | 10.6M | 11.03M | 10.95M | 9.41M | 8.42M | 8.42M | 7.54M | 6.09M |
Shares Outstanding (Diluted) | 136.74M | 25.48M | 25.48M | 25.48M | 36.96M | 30.87M | 24.23M | 18.55M | 25.48M | 14.27M | 13.01M | 13.01M | 12.84M | 12.83M | 11.37M | 10.6M | 11.03M | 10.95M | 9.41M | 8.42M | 8.42M | 7.54M | 6.09M |
EPS (Basic) | -0.15 | -0.05 | -0.38 | -0.38 | -0.55 | -1.50 | 0.72 | 0.31 | 1.91 | -8.01 | -0.86 | -1 | -1.61 | -0.52 | -1.60 | -1.35 | -1.60 | -1.80 | -1.60 | -1.59 | -1.40 | -1.74 | -2.37 |
EPS (Diluted) | -0.15 | -0.17 | -0.38 | -0.52 | -0.55 | -1.50 | 0.72 | 0.31 | -0.89 | -8.01 | -0.86 | -1 | -1.61 | -0.52 | -1.60 | -1.35 | -1.60 | -1.80 | -1.60 | -1.59 | -1.40 | -1.80 | -2.37 |
EBITDA | -20.28M | -14M | -13.45M | -14.55M | -20.07M | -12.36M | -21.58M | 5.72M | 44.44M | -18.91M | -10.3M | -16.74M | -20.66M | -6.83M | -15.68M | -13.93M | -16.97M | -18.86M | -14.06M | -13.09M | -11.89M | -12.77M | -14.22M |
EBIT | -20.28M | -14.03M | -13.48M | -14.58M | -20.1M | -12.39M | -21.61M | 5.69M | 44.41M | -18.94M | -10.32M | -16.75M | -20.68M | -6.84M | -15.69M | -13.98M | -17.02M | -18.91M | -14.11M | -13.14M | -11.94M | -12.85M | -14.3M |
Depreciation & Amortization | -60.49K | 30.42K | 30.07K | 29.74K | 29.41K | 29.1K | 28.8K | 28.8K | 28.67K | 28.2K | 28.2K | 11.22K | 11.19K | 11K | 10.78K | 51.47K | 51.27K | 51.09K | 50.87K | 50.67K | 48.18K | 82.17K | 81.12K |
Add to Watchlist
Select watchlists to add or remove OTLK